Why Lenz Therapeutics Stock Crashed Today

Lenz Therapeutics (NASDAQ: LENZ) banal tumbled 11.2% done 9:50 a.m. ET Tuesday aft missing connected Q4 earnings.

Heading into the report, analysts forecast Lenz to suffer $0.90 per stock connected quarterly income of $3.1 million. Lenz mislaid $1.16 per stock connected income of lone $1.6 million.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

Lens is simply a pharmaceutical institution processing a aesculapian alternate to speechmaking glasses for attraction of presbyopia -- blurry adjacent imaginativeness that increases astir property 50 successful astir adults. The company's VIZZ oculus drops are sold successful single-dose vials and tin temporarily amended adjacent imaginativeness for up to 10 hours erstwhile taken erstwhile regular by causing the oculus muscles to declaration and absorption better.

The institution launched income of VIZZ successful October 2025, truthful Q4 was its "launch quarter." The institution says it's connected gait to deed 45,000 prescriptions written done the extremity of Q1 2026, by much than 10,000 oculus doctors. Unfortunately, Q4 uptake doesn't look to person been arsenic beardown arsenic Wall Street was expecting.

Mostly, this seems to person been owed to the company's selling, general, and administrative expenses (SG&A) astir quadrupling during the archetypal income push.

Will SG&A costs abate successful 2026, allowing Lenz to crook profitable? Unfortunately, absorption didn't springiness overmuch guidance astir what to expect successful the coming year. To the contrary, the statement of prescriptions written -- "over 45,000 paid prescriptions from motorboat done Q1 2026" -- really obscures any accusation we mightiness person gotten connected publication maturation betwixt the 2025 motorboat 4th and the archetypal sequential 2026 quarter.

So we're inactive astatine a nonaccomplishment arsenic to however good acceptance of the caller merchandise is growing.

Investors don't similar being kept successful the dark, and that's wherefore Lenz banal is selling off.

Before you bargain banal successful Lenz Therapeutics, see this:

The Motley Fool Stock Advisor expert squad conscionable identified what they judge are the 10 champion stocks for investors to bargain now… and Lenz Therapeutics wasn’t 1 of them. The 10 stocks that made the chopped could nutrient monster returns successful the coming years.

Consider erstwhile Netflix made this database connected December 17, 2004... if you invested $1,000 astatine the clip of our recommendation, you’d person $503,592!* Or erstwhile Nvidia made this database connected April 15, 2005... if you invested $1,000 astatine the clip of our recommendation, you’d person $1,076,767!*